Seeger Weiss LLP Reports That Xarelto Multidistrict Litigation Bellwether Trial Dates Set For Early 2017

Nov 13, 2015, 06:00 ET from Seeger Weiss LLP

NEW YORK, Nov. 13, 2015 /PRNewswire/ -- Seeger Weiss LLP is reporting that the bellwether trial dates have been set for the Xarelto Multidistrict Litigation (MDL). Presiding District Court Judge Eldon Fallon has issued an order for the first four scheduled bellwether trials to commence. The first two will be held in the Eastern District of Louisiana; the first starting on February 6, 2017, and the second starting on March 13, 2017. The next trial will be held in Mississippi on April 24, 2017. The fourth will be held in Texas on May 30, 2017.

Xarelto has been connected to serious health issues such as gastrointestinal bleeding, brain hemorrhaging, blood clots, and stroke. Plaintiffs have alleged, in part, that the defendants responsible for developing and marketing Xarelto, Bayer Healthcare, Janssen Pharmaceuticals, and Johnson & Johnson, failed to warn doctors and patients that patients on Xarelto would require medical monitoring and that they were at an increased risk for certain types of bleeding events. Further, plaintiffs claim the manufacturers failed to notify patients that there was no reversal agent that could quickly stop the anticoagulant effects of Xarelto, thereby increasing the risk of uncontrolled bleeding in some patients.

The upcoming bellwether trials are intended to give plaintiffs and their attorneys in the remaining number of cases a better idea as to how juries will respond to certain evidence and testimonies that will be recurring throughout all similar trials.

Several partners at Seeger Weiss LLP serve as leadership in this multidistrict litigation based in the US District Court for the Eastern District of Louisiana.

Seeger Weiss LLP is one of the nation's leading trial law firms handling complex individual, mass and class action litigation on behalf of consumers, investors, injured persons and whistleblowers. The firm, with offices in New York, Philadelphia and New Jersey, represents plaintiffs throughout litigation and as trial counsel in a variety of practice areas, including financial, securities and investment fraud, pharmaceutical injury, consumer protection, qui tam (whistleblower cases), environmental and asbestos exposures, personal injury and medical malpractice, product defect, antitrust, and commercial disputes. For more information, go to

For more information on Xarelto or if you believe you have been injured by using Xarelto, go to

Logo -

Christopher A. Seeger, (877) 709-5531 or
Jeffrey S. Grand (877) 709-5531 or

SOURCE Seeger Weiss LLP